IFRS Foundation

Health Care Delivery

Select Language
Current language: English
The Health Care Delivery industry owns and manages hospitals, clinics and other health care related facilities. Entities provide a range of services, including inpatient and outpatient care, surgery, mental health, rehabilitation and clinical laboratory services. Demand for health care delivery services is driven largely by insurance coverage rates, demographics, illness and injury rates. The industry is characterised by high fixed labour and facilities costs, and an increased regulatory focus on reduced costs of care and improved outcomes. Health care delivery entities also face significant competition for patients and resources from private, non-profit and religious health care systems.

Relevant Issues (11 of 26)

Why are some issues greyed out? The SASB Standards vary by industry based on the different sustainability-related risks and opportunities within an industry. The issues in grey were not identified during the standard-setting process as the most likely to be useful to investors, so they are not included in the Standard. Over time, as the ISSB continues to receive market feedback, some issues may be added or removed from the Standard. Each company determines which sustainability-related risks and opportunities are relevant to its business. The Standard is designed for the typical company in an industry, but individual companies may choose to report on different sustainability-related risks and opportunities based on their unique business model.

Disclosure Topics

What is the relationship between General Issue Category and Disclosure Topics? The General Issue Category is an industry-agnostic version of the Disclosure Topics that appear in each SASB Standard. Disclosure topics represent the industry-specific impacts of General Issue Categories. The industry-specific Disclosure Topics ensure each SASB Standard is tailored to the industry, while the General Issue Categories enable comparability across industries. For example, Health & Nutrition is a disclosure topic in the Non-Alcoholic Beverages industry, representing an industry-specific measure of the general issue of Customer Welfare. The issue of Customer Welfare, however, manifests as the Counterfeit Drugs disclosure topic in the Biotechnology & Pharmaceuticals industry.
General Issue Category
(Industry agnostic)

Disclosure Topics (Industry specific) for: Health Care Delivery

Energy Management
  • Energy Management

    Health Care Delivery entities operate energy-intensive facilities and rely on both purchased electricity and fuel. The consumption of both can contribute to environmental impacts, including climate change and pollution. Legislative attempts to limit these impacts and to incentivise energy efficiency and renewable energy may result in price volatility associated with fossil fuels and conventional electricity. Entities that improve energy efficiency may decrease costs and limit exposure to energy price fluctuations.
Waste & Hazardous Materials Management
  • Waste Management

    Health Care Delivery entities generate a significant amount of regulated medical and pharmaceutical waste. Disposal fees for these types of waste are typically higher than that of conventional waste and may present a significant cost for the industry. Entities that reduce the amount of waste generated by enhanced waste segregation strategies, recycling and reuse may limit their exposure to these costs.
Data Security
  • Patient Privacy & Electronic Health Records

    The Health Insurance Portability and Accountability Act (HIPAA) requires health care providers to establish administrative, physical, and technical safeguards to protect the integrity, confidentiality, and availability of patient health information. Failure to comply with such regulations can lead to civil and criminal penalties. The extent and enforcement of these fines was strengthened by the American Recovery and Reinvestment Act (ARRA). The ARRA also established financial incentives for the meaningful use of electronic health records, as well as reduced Medicare payments for entities that fail to demonstrate meaningful use. Although meaningful use was supplanted by Promoting Interoperability by the Medicare Access and CHIP Reauthorization Act (MACRA), financial incentives and penalties remain tied to the effective use of electronic health records. As legislative efforts continue to promote the use of electronic health records and health care delivery entities face increasing threats related to cybersecurity, disclosure on the use of electronic health records and data security will allow shareholders to monitor performance in these areas.
Access & Affordability
  • Access for Low-Income Patients

    The Patient Protection and Affordable Care Act (PPACA) expanded the number of insured individuals. However, more than 10 percent of the adults in the U.S. remain uninsured. Health care delivery entities will continue to face challenges associated with serving uninsured and low-income patients. These challenges are likely to be compounded by reductions in Disproportionate Share Hospital (DSH) payments. Disclosure on how entities manage the provision of care to uninsured populations and shifting DSH allocations will allow shareholders to understand the associated risks and opportunities.
Product Quality & Safety
  • Quality of Care & Patient Satisfaction

    The ability to deliver quality care and ensure patient satisfaction is an essential value driver for health care delivery entities. The link between performance in this area and shareholder value was strengthened by the Patient Protection and Affordable Care Act (PPACA). Included in the Act’s provisions, is the establishment of the Hospital Value-Based Purchasing Program, which provides incentive payments, based on performance on a series of health care quality measures. In addition, the PPACA created programs that reduce inpatient payments for hospitals with excessive readmissions rates and hospital-acquired conditions.
Customer Welfare
  • Management of Controlled Substances

    The Health Care Delivery industry is in a unique position with respect to the evolving opioid epidemic in the U.S. As one of the largest prescribers of opioids, the industry has contributed to an increase in the use of these substances and subsequently to a rise in addiction levels. As the providers of care, the industry also treats individuals who are suffering from addiction and related health concerns. Although health care delivery entities do not typically face direct costs associated with the prescription of opioids, they face significant costs in addressing the health care needs of those suffering from addiction and related illnesses. Industry-wide efforts to reevaluate approaches to pain management through the development of new policies, training, and oversight may have financially material impacts.
Selling Practices & Product Labeling
  • Pricing & Billing Transparency

    In the U.S., concern over pricing and billing transparency in the Health Care Delivery industry has led to numerous legislative efforts at both the state and federal level. More than 40 states report information on charges or payment rates, and make the information available to the public. For hospitals accepting Medicare patients, the Centres for Medicare & Medicaid Services (CMS) provides average charges per patient and average Medicare payments for the 30 most common ambulatory procedures and the most frequent diagnosis-related groups. Beginning in 2019, CMS is also likely to require that hospitals publish a list of their current standard charges online, and that these charges be updated annually. This would strengthen requirements established in the Patient Protection and Affordable Care Act (PPACA), and be similar to existing requirements in numerous states. These legislative and regulatory efforts, coupled with increased emphasis on health care cost containment, may enhance scrutiny on the pricing and billing practices of entities in this industry. Firms that are able to achieve compliance and transparent pricing structures may be better positioned to protect shareholder value.
Employee Health & Safety
  • Employee Health & Safety

    The Health Care Delivery industry is heavily dependent on a skilled workforce, and employees are routinely exposed to injury, illness, and infection during their regular duties. Relative to other industries, Health Care Delivery has one of the highest rates of injury and illness. Entities that are able to manage this issue more effectively can reduce costs associated with workers’ compensation, productivity, morale, and employee retention. Entities often mitigate risks by implementing proactive health and safety management protocols, developing training requirements for employees, and conducting regular audits of their own practices.
Employee Engagement, Diversity & Inclusion
  • Employee Recruitment, Development & Retention

    Health care delivery entities will continue to face increased competition for physicians due to increased demand which is intensified by current and future shortages. The ongoing ability to recruit, develop, and retain health care practitioners is critical to success in this industry and disclosure on related performance indicators allows shareholders to understand how entities are managing this important human capital issue.
Physical Impacts of Climate Change
  • Climate Change Impacts on Human Health & Infrastructure

    An increase in extreme weather events associated with climate change may present physical threats to health care delivery facilities and create challenges in serving affected populations. Coupled with the potential spread of infectious diseases and food and water scarcity, these events may present material implications for the Health Care Delivery industry.
Business Ethics
  • Fraud & Unnecessary Procedures

    Health care delivery entities in the U.S. are subject to significant fines and penalties under the Federal False Claims Act and similar state laws. Entities that receive at least $5 million annually in Medicaid payments must have written policies for all employees and contractors regarding false claims, false statements, and whistleblower protections under these laws. The ability to ensure compliance in this area may have material implications for health delivery entities.

Select up to 4 industries

Current Industry: Health Care Delivery

Health Care
Consumer Goods
Extractives & Minerals Processing
Food & Beverage
Renewable Resources & Alternative Energy
Resource Transformation
Technology & Communications

Tell Us About Yourself

While it’s free to download SASB Standards, we request the following information to better understand how the Standards are being used.

Content Use Policy

The SASB Standards are made available for free for non-commercial use, such as corporate disclosure. The content in the SASB Standards is copyrighted. All rights reserved. Commercial use of the content in the SASB Standards – including for investment analysis, data services, and product development - is not permitted without consent. To request more information, please contact us at: [email protected].

Stay Informed: Please tick the below boxes to subscribe to specific email updates. The IFRS Foundation is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow the IFRS Foundation to store and process the personal information submitted above to provide you the content requested.

We encourage you to visit the IFRS Foundation notification dashboard to register for an account and sign up for additional email subscriptions you may be interested in, such as notifications about the ISSB and the IFRS Sustainability Disclosure Standards.